Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Glen Davis is active.

Publication


Featured researches published by Michael Glen Davis.


Journal of Inorganic Biochemistry | 2003

Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component

Kevin Gene Peters; Michael Glen Davis; Brian W. Howard; Matthew Pokross; Vinit Rastogi; Conrad Diven; Kenneth D. Greis; Elaine Eby-Wilkens; Matthew B. Maier; Artem G. Evdokimov; Shari Joy Soper; Frank Genbauffe

Organovanadium compounds have been shown to be insulin sensitizers in vitro and in vivo. One potential biochemical mechanism for insulin sensitization by these compounds is that they inhibit protein tyrosine phosphatases (PTPs) that negatively regulate insulin receptor activation and signaling. In this study, bismaltolato oxovanadium (BMOV), a potent insulin sensitizer, was shown to be a reversible, competitive phosphatase inhibitor that inhibited phosphatase activity in cultured cells and enhanced insulin receptor activation in vivo. NMR and X-ray crystallographic studies of the interaction of BMOV with two different phosphatases, HCPTPA (human low molecular weight cytoplasmic protein tyrosine phosphatase) and PTP1B (protein tyrosine phosphatase 1B), demonstrated uncomplexed vanadium (VO(4)) in the active site. Taken together, these findings support phosphatase inhibition as a mechanism for insulin sensitization by BMOV and other organovanadium compounds and strongly suggest that uncomplexed vanadium is the active component of these compounds.


Experimental Biology and Medicine | 2005

A Nonspecific Phosphotyrosine Phosphatase Inhibitor, Bis(maltolato)oxovanadium(IV), Improves Glucose Tolerance and Prevents Diabetes in Zucker Diabetic Fatty Rats:

Carol Winter; Jana S. Lange; Michael Glen Davis; Gina S. Gerwe; Thomas R. Downs; Kevin Gene Peters; Bhavani Kasibhatla

The molecular basis of insulin resistance, a major risk factor for development of Type II diabetes, involves defective insulin signaling. Insulin-mediated signal transduction is negatively regulated by the phosphotyrosine phosphatase, PTP1B, and numerous studies have demonstrated that organo-vanadium compounds, which are nonselective phosphotyrosine phosphatase inhibitors, have insulin-mimetic properties. However, whether or not vanadium compounds can prevent the transition from insulin resistance to overt diabetes is unknown. We compared the ability of bis(maltolato)oxovanadium(IV) (BMOV), an orally bioavailable organo-vanadium compound, and rosiglitazone maleate (RSG), a known insulin sensitizer, to prevent development of diabetes in Zucker diabetic fatty (ZDF) rats. Treatment began at 6 weeks of age when animals are insulin resistant and hyperinsulinemic, but not yet hyperglycemic, and ended at 12 weeks of age, which is 4 weeks after ZDF rats typically develop overt diabetes. BMOV-treated ZDF rats did not develop hyperglycemia, showed significant improvement in insulin sensitivity, and retained normal pancreatic islet morphology and endocrine cell distribution, similar to RSG-treated animals. BMOV and RSG treatment also prevented the hyperphagia and polydipsia present in untreated ZDF rats; however, BMOV-treated ZDF rats gained much less weight than did RSG-treated animals. Circulating levels of adiponectin decreased in untreated ZDF rats compared to lean controls, but these levels remained normal in BMOV-treated ZDF rats. In contrast, in RSG-treated ZDF rats, plasma adiponectin levels were nearly 4-fold higher than in lean control rats, primarily as a result of a large increase in the amount of low–molecular weight forms of adiponectin in circulation. These data demonstrate that phosphatase inhibition offers a new approach to diabetes prevention, one that may have advantages over current approaches.


PeerJ | 2014

Human hair shaft proteomic profiling: Individual differences, site specificity and cuticle analysis

Chelsea N. Laatsch; Blythe Durbin-Johnson; David M. Rocke; Sophie Mukwana; Abby Ballard Newland; Michael J. Flagler; Michael Glen Davis; Richard A. Eigenheer; Brett S. Phinney; Robert H. Rice

Hair from different individuals can be distinguished by physical properties. Although some data exist on other species, examination of the individual molecular differences within the human hair shaft has not been thoroughly investigated. Shotgun proteomic analysis revealed considerable variation in profile among samples from Caucasian, African–American, Kenyan and Korean subjects. Within these ethnic groups, prominent keratin proteins served to distinguish individual profiles. Differences between ethnic groups, less marked, relied to a large extent on levels of keratin associated proteins. In samples from Caucasian subjects, hair shafts from axillary, beard, pubic and scalp regions exhibited distinguishable profiles, with the last being most different from the others. Finally, the profile of isolated hair cuticle cells was distinguished from that of total hair shaft by levels of more than 20 proteins, the majority of which were prominent keratins. The cuticle also exhibited relatively high levels of epidermal transglutaminase (TGM3), accounting for its observed low degree of protein extraction by denaturants. In addition to providing insight into hair structure, present findings may lead to improvements in differentiating hair from various ethnic origins and offer an approach to extending use of hair in crime scene evidence for distinguishing among individuals.


International Journal of Cosmetic Science | 2014

Role of copper in photochemical damage to hair

Jennifer Mary Marsh; R. Iveson; Michael J. Flagler; Michael Glen Davis; A. B. Newland; Kenneth D. Greis; Yiping Sun; T. Chaudhary; E. R. Aistrup

The objective of this work was to identify whether low levels of redox metals such as copper will accelerate damage to hair on exposure to UV irradiation and whether this damage can be prevented.


International Journal of Cosmetic Science | 2015

Advanced hair damage model from ultra-violet radiation in the presence of copper

Jennifer Mary Marsh; Michael Glen Davis; Michael J. Flagler; Yiping Sun; T. Chaudhary; M. Mamak; D. W. McComb; R. E. A. Williams; Kenneth D. Greis; L. Rubio; L. Coderch

Damage to hair from UV exposure has been well reported in the literature and is known to be a highly complex process involving initiation via absorption of UV light followed by formation and propagation of reactive oxygen species (ROS). The objective of this work was to understand these mechanisms, explain the role of copper in accelerating the formation of ROS and identify strategies to reduce the hair damage caused by these reactive species.


International Journal of Cosmetic Science | 2015

Preserving fibre health: reducing oxidative stress throughout the life of the hair fibre.

Jennifer Mary Marsh; Michael Glen Davis; R. L. Lucas; R. Reilman; P. B. Styczynski; C. Li; M. Mamak; D. W. McComb; R. E. A. Williams; Simon Paul Godfrey; K. R. Navqi; Victor Chechik

Hair health is an important attribute to women globally – specifically attributes such as shine, healthy tips, frizz‐free and strength. However, many women will claim to have at least moderate hair damage caused by habits and practices such as washing, combing and brushing, use of heated implements and regular use of chemical treatments. The objective of this work was to investigate two mechanisms of damage – hair colouring and UV exposure – where oxidative processes are involved. The role of copper in these oxidative processes was then investigated: its presence in hair and its consequent impact on hair damage via free radical formation. Finally, the role of chelants N,N’‐ethylene diamine disuccinic acid (EDDS) and histidine in preventing free radical formation was investigated and shown to improve hair health.


Cardiovascular Research | 2006

Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.

Andrew N. Carr; Brian W. Howard; Hsiao T. Yang; Elaine Eby-Wilkens; Paula Loos; Alex Varbanov; Angela Qu; Jeffrey Demuth; Michael Glen Davis; Alan D. Proia; Ronald L. Terjung; Kevin Gene Peters


American Journal of Physiology-heart and Circulatory Physiology | 2004

Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease

Andrew N. Carr; Michael Glen Davis; Elaine Eby-Wilkens; Brian W. Howard; Bryan A. Towne; Thomas Edward Dufresne; Kevin Gene Peters


Archive | 2007

HPTPbeta as a target in treatment of angiogenesis mediated disorders

Kevin Gene Peters; Michael Glen Davis


Archive | 2007

Pharmaceutical compositions that modulate HPTPbeta activity

Kevin Gene Peters; Michael Glen Davis

Collaboration


Dive into the Michael Glen Davis's collaboration.

Top Co-Authors

Avatar

Kenneth D. Greis

University of Cincinnati Academic Health Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge